Sector: Health Care
Director information for BOSTON SCIENTIFIC CORP (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Arthur C. Butcher | Executive Vice President and Group President, MedSurg and Asia Pacific | 55 | ["MBA from Columbia University","BA in international relations from the University of Pennsylvania","held management roles since 1997","deep experience across Company’s divisions"] | ["Global Council for Inclusion"] | 2026 |
| Cathy R. Smith | Executive Vice President & Chief Financial Officer; Director | 62 | ["Executive leadership experience","Financial expertise as a chief financial officer","Audit committee financial expert","Public company governance","Board experience","Corporate transactions insight","Human capital management","Compensation","Cybersecurity and IT oversight","Sustainability","Technology and innovation","Global business experience","Healthcare industry background"] | ["Audit","Nominating and Governance","Executive Compensation and Human Resources","Risk, Science and Technology"] | 2026 |
| Cheryl Pegus | Chair | [] | ["Audit","Executive Compensation and Human Resources","Nominating and Governance","Risk, Science and Technology","Risk, Science and Technology Committee"] | 2026 | |
| Cheryl Pegus, M.D. | Chair and Chief Executive Officer | 62 | ["CEO and executive leadership experience in healthcare","Expertise in public health policy","Clinical care and business strategy","Experience in regulatory matters","Human capital management","Executive compensation","Technology and innovation","Proven track record of advancing healthcare quality and affordability"] | ["Executive Compensation and Human Resources","Risk, Science and Technology"] | 2026 |
| Christophe P. Weber | Chief Executive Officer, Takeda Pharmaceutical Company, Limited; Director | 59 | ["extensive executive leadership and chief executive officer experience","background in business development and corporate transactions","global business strategy and operations","public company governance and board experience","expertise in legal, regulatory and risk management matters","public policy and government affairs","human capital management and executive compensation","perspectives in healthcare industry dynamics","sustainability","technology and innovation"] | ["Executive Compensation and Human Resources","Risk, Science and Technology","Audit","Nominating and Governance","Risk, Science and Technology Committee"] | 2026 |
| Daniel J. Brennan | Former Executive Vice President and Chief Financial Officer | [] | [] | 2026 | |
| David C. Habiger | Vice Chairman of the Board | 57 | ["Chief Executive Officer and executive leadership experience","experience in technology and innovation","deep expertise in corporate governance","financial accounting","risk management","global business strategy and operations"] | ["Audit","Executive Compensation and Human Resources","Nominating and Governance","Risk, Science and Technology"] | 2026 |
| David S. Wichmann | Former Chief Executive Officer, UnitedHealth Group Incorporated; Director | 63 | ["Co-Founder of Jory Capital","Former Chief Executive Officer of UnitedHealth Group Incorporated","President of UnitedHealth Group","Chief Financial Officer of UnitedHealth Group","Experience as a partner at Arthur Andersen & Co.","Chief Financial Officer of Advance Machine Company","Director of Privia Health Group, Inc.","Board member of other public companies"] | ["Audit (Chair, Financial Expert)","Risk, Science and Technology","Audit","Executive Compensation and Human Resources","Nominating and Governance","Risk, Science and Technology Committee"] | 2026 |
| Edward J. Ludwig | Former Chairman of the Board and Chief Executive Officer, Becton, Dickinson and Company; Director | 74 | ["Former Chairman of the Board of Becton, Dickinson and Company","Chief Executive Officer of Becton, Dickinson and Company","President of Becton, Dickinson and Company","Senior financial analyst at Becton, Dickinson and Company","Senior auditor with Coopers and Lybrand","Financial and strategic analyst at Kidde, Inc.","Director of POCARED Diagnostics Ltd","Former director of CVS Health Corporation","Former director of Aetna, Inc.","Former director of Xylem, Inc.","Vice Chair of the board of trustees of the Hackensack University Medical Center Network","Chairman of the Board of GRIP Molecular","MBA from Columbia University","BA in economics and accounting from The College of Holy Cross"] | ["Audit (Financial Expert)","Nominating and Governance","Audit","Executive Compensation and Human Resources","Risk, Science and Technology"] | 2026 |
| Ellen M. Zane | CEO Emeritus, Tufts Medical Center; Director | 74 | ["CEO Emeritus at Tufts Medical Center","Founding Chair at Tufts Medicine","President and Chief Executive Officer of Tufts Medical Center from 2004 to 2011","Network President for Mass General Brigham","CEO of Quincy Hospital","Director of several privately-held companies","Director of Haemonetics Corporation and Synchrony Financial","Honorary Degrees from Curry College, Stonehill College, Bentley University and University of Massachusetts-Dartmouth","MA in audiology and speech-language pathology from Catholic University of America","BA from George Washington University","Experience in business development and corporate transactions","Corporate governance and sustainability","Finance, human capital management, public policy and government affairs"] | ["Executive Compensation and Human Resources (Chair)","Nominating and Governance","Audit","Executive Compensation and Human Resources","Risk, Science and Technology"] | 2026 |
| Jeffrey B. Mirviss | Former Executive Vice President and President, Peripheral Interventions | [] | [] | 2026 | |
| Jessica L. Mega | Director | [] | ["Audit","Executive Compensation and Human Resources","Nominating and Governance","Risk, Science and Technology","Risk, Science and Technology Committee"] | 2026 | |
| Jessica L. Mega, M.D. | Co-Founder and Former Chief Medical and Scientific Officer, Verily Life Sciences, LLC | 51 | ["Leader at the intersection of technology, life sciences and healthcare","Co-founded Verily Life Sciences","Served as Chief Medical and Scientific Officer from 2015 to January 2023","Clinical background and executive experience in life sciences","Experience in technology, global business strategy and operations","Background in academia, public policy, government, and regulatory affairs"] | ["Executive Compensation and Human Resources","Risk, Science and Technology"] | 2026 |
| Jonathan R. Monson | Executive Vice President and Chief Financial Officer | 52 | ["BA degree in economics and accounting from College of the Holy Cross","Certified public accountant","Senior auditor at Arthur Anderson L.L.P.","Roles of increasing responsibility since joining the Company in 1999"] | [] | 2026 |
| Joseph M. Fitzgerald | Executive Vice President and Group President, Cardiovascular | 62 | ["MBA from Southern Illinois University with a concentration in marketing and finance","BS in business from Indiana University","variety of management positions in Cardiovascular business"] | ["Global Council for Inclusion","Women’s Network"] | 2026 |
| Michael F. Mahoney | CEO, Chairman of the Board; Chairman of the Board, President and Chief Executive Officer | 61 | ["Management experience leading complex global organizations","Expertise in building strong leadership teams","Developing international markets","Proven ability to execute successful business strategies","Drive operational excellence"] | ["Board of Directors of Baxter International Inc.","Director of CVS Health Corporation","Board of the Boys & Girls Club of Boston","Chair of the Board of Governors of Boston College CEO Club","Member of the American Heart Association CEO Roundtable","Audit","Executive Compensation and Human Resources","Nominating and Governance","Risk, Science and Technology"] | 2026 |
| Miriam O’Sullivan | Senior Vice President, Chief Human Resources Officer | 45 | ["Senior Vice President, Chief Human Resources Officer","Vice President of Human Resources, Cardiology (2021 to 2025)","Vice President of Human Resources, Interventional Cardiology (2019 to 2021)","Vice President of Human Resources, Global Operations (2017 to 2018)","Director of Human Resources for manufacturing site in Cork, Ireland"] | ["Global Council for Inclusion"] | 2026 |
| Susan E. Morano | Former Vice President Business Development and Strategic Operations, Johnson & Johnson Medtech; Chair | 61 | ["executive leadership experience in the medtech industry","extensive experience in global business strategy and operations","healthcare","human capital","corporate governance","sustainability","financial expertise"] | ["Audit","Nominating and Governance","Executive Compensation and Human Resources","Risk, Science and Technology"] | 2026 |
| Vance R. Brown | Executive Vice President, General Counsel and Corporate Secretary | 56 | ["JD from Harvard Law School","BA from University of Western Ontario","variety of legal and compliance roles since 2001","VP, Chief Corporate Counsel and Assistant Secretary from 2010 to 2021","leadership in international legal teams"] | ["Global Council for Inclusion"] | 2026 |
